FDA Inspection 981353 — Hikma Pharmaceuticals LLC

Hikma Pharmaceuticals LLC — FEI 3002806351

The FDA completed an inspection of Hikma Pharmaceuticals LLC on July 27, 2016 in Amman. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 27, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Amman (Jordan)

Citations

IDCFRDescription
121521 CFR 211.67(b)Written procedures not established/followed
179021 CFR 211.80(b)Handling and Storage to Prevent Contamination